Miromatrix Medical Inc. (MIRO) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Eden Prairie, MN, 미국. 현재 CEO는 Jeffrey James Ross.
MIRO 을(를) 보유 IPO 날짜 2021-06-24, 76 명의 정규직 직원, 에 상장 NASDAQ Capital Marke, 시가총액 $92.95M.
Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. The company has collaborations with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.
